In a filing, Xtant Medical Holdings Inc revealed its Chief Commercial Officer Brandt Kevin D acquired Company’s shares for reported $49837.0 on Nov 17 ’23. In the deal valued at $1.20 per share,41,670 shares were bought. As a result of this transaction, Brandt Kevin D now holds 815,860 shares worth roughly $0.67 million.
BTIG Research initiated its Xtant Medical Holdings Inc [XTNT] rating to a Buy in a research note published on December 05, 2023; the price target was $2. A number of analysts have revised their coverage, including Maxim Group’s analysts, who remained covering the stock and in mid November has reiterated a ‘”a Buy”‘ rating for it. Maxim Group also remained covering XTNT and reiterated its “Buy” recommendation on February 14, 2018.
Price Performance Review of XTNT
On Tuesday, Xtant Medical Holdings Inc [AMEX:XTNT] saw its stock fall -7.25% to $0.82. Over the last five days, the stock has lost -8.74%. Xtant Medical Holdings Inc shares have fallen nearly -27.75% since the year began. Nevertheless, the stocks have risen 30.62% over the past one year. While a 52-week high of $1.45 was reached on 01/04/24, a 52-week low of $0.60 was recorded on 04/16/24. SMA at 50 days reached $0.9991, while 200 days put it at $1.1046. A total of 0.4 million shares were traded, compared to the trading of 0.28 million shares in the previous session.
Levels Of Support And Resistance For XTNT Stock
The 24-hour chart illustrates a support level at 0.7456, which if violated will result in even more drops to 0.6748. On the upside, there is a resistance level at 0.9026. A further resistance level may holdings at 0.9888. The Relative Strength Index (RSI) on the 14-day chart is 38.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0264, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.52%. Stochastics %K at 42.09% indicates the stock is a holding.
